#NewAseBioMember | “For us, AseBio is a key platform for connection, visibility, and collaboration within the Spanish biotech ecosystem”
Meet Maieutics Research Solutions, our new member. We talk with Lander Ezequiel Senderowicz, Operational Manager
AseBio. What does your company's work bring to the table and what is its strength?
Ezequiel Senderowicz. Maieutics provides expert and agile clinical oversight to ensure trials are delivered on time, with quality, and free from critical deviations.
Our strength lies in anticipating risks that could compromise the trial, offering a flexible, senior-led solution tailored to each company and focused on real, measurable results.
AseBio. What is AseBio for you?
Ezequiel Senderowicz. For us, AseBio is a key platform for connection, visibility, and collaboration within the Spanish biotech ecosystem. It enables us to expand our network of contacts and strategic partners.
AseBio. When did you first hear about AseBio?
Ezequiel Senderowicz. A few years ago, in a LinkedIn post
AseBio. What do you expect from being part of an association like AseBio?
Ezequiel Senderowicz. To expand our network of contacts and collaborators within the sector
AseBio. What is the biggest challenge facing the biotech sector or your company?
Ezequiel Senderowicz. The sector’s goal is to grow without the need for heavy financial investment. Our company’s goal is to be known—to let others see who we are and what we bring